The Pharmaceutical Care Services Department recognizes the need to participate in the development of training programs necessary to ensure the ongoing availability of pharmacy practitioners with the knowledge and skills required to promote, recommend, and deliver high quality pharmaceutical care services.
Our ASHP-accredited PGY2 Oncology residency program is dedicated to providing the resident with the knowledge, attitude, and skills necessary to assure optimal drug therapy outcomes, and to nurture the life skills and professionalism required to contribute positively in the health care environment.
The PGY2 Oncology pharmacy residency seeks to prepare pharmacists to practice as an oncology specialist pharmacist in the inpatient and outpatient ambulatory clinic settings for adult and pediatric oncology patients.
The Providence Alaska Medical Center Oncology Residency Goals are as follows:
Successful completion of the residency program involves meeting the residency program goals and objectives identified at the beginning of the residency year.
ASHP standards are used to define program objectives. An assessment of the resident’s knowledge, skills, experiences, and interests will be performed prior to the beginning of the residency year. Objectives will be individualized for the incoming residents based on their previous learning experiences.
PharmAcademic is used to document the resident’s progress throughout the program. Informal assessments and review of specified longitudinal goals with the RPD will occur regularly during the year. Formative evaluations will occur during experiences and summative evaluations will occur at the end of each learning experience. Residents will self-evaluate throughout the residency. Residents will evaluate preceptors and learning experiences formally at the end of each learning experience.